Register Now to View This On-demand Webinar!
(Original Broadcast: Tuesday, June 30, 2026)
Short stature is a common presentation in pediatric endocrinology, with many patients ultimately classified as having idiopathic or familial short stature. However, underlying genetic conditions such as hypochondroplasia may be under-recognized due to variable and often subtle clinical features.
Learning objectives:
Describe key considerations in short stature evaluation, including features suggestive of hypochondroplasia
Recognize clinical findings and growth patterns that may prompt consideration of a genetic etiology and appropriate diagnostic evaluation
Discuss clinical implications and management considerations relevant to the care of patients with hypochondroplasia
Expert Speakers
Chief of Endocrinology
Children’s National Hospital
Professor of Pediatrics
George Washington University
School of Medicine and Health Sciences
Washington, District of Columbia
Division Head
Medical Director, Cellular and
Gene Therapy Program
Edwards Family Chair in Genetics
and Rare Diseases
Professor of Pediatrics (Genetics, Genomics and Metabolism)
Northwestern University Feinberg School of Medicine
Chicago, Illinois
This Webinar will review key considerations in short stature evaluation that may prompt suspicion for hypochondroplasia, with a focus on clinical recognition and the role of genetic testing in supporting earlier and more accurate diagnosis and informing clinical management.
Register now
This Webinar is intended for Healthcare Professionals only.
If you have questions or need any additional information about the Webinar, please contact us at questions@inbiopharma.com.
BioMarin Pharmaceutical Inc. complies with the Open Payments Act and the PhRMA Guidelines. This event is not eligible for CME credits.
MED-SC-0641 / June 2026